1
EXHIBIT 10.93
SECURITIES PURCHASE AGREEMENT
THIS SECURITIES PURCHASE AGREEMENT (this "Agreement"), is made as of
April 29, 1998, by and between American Biomed, Inc., a corporation organized
under the laws of the State of Delaware, U.S.A., with headquarters located at
00000 Xxxxxx'x Xxxx Xxxx, Xxxxx 000, Xxx Xxxxxxxxx, Xxxxx 00000 (the "Company")
and the buyer set forth on the execution page hereof (the "Buyer").
RECITALS
A. The Company and the Buyer are executing and delivering this
Agreement in reliance upon the exemption from securities registration afforded
by the provisions of Regulation D ("Regulation D") as promulgated by the United
States Securities and Exchange Commission (the "SEC") under the Securities Act
of 1933, as amended (the "1933 Act");
B. The Buyer desires to purchase from the Company, and the Company
desires to sell to the Buyer, for the amounts and upon the terms and conditions
stated in this Agreement, in a closing or closings (each a "Closing") as herein
described, certain shares of the Company's preferred stock as listed in Recitals
B(i) and B(ii) immediately below, along with certain warrants of the Company as
listed in Recital B(iii) below.
(i) At the first Closing (the "First Closing"), shares of
the Company's Series D Convertible Preferred Stock
(the "Series D Shares"), which may be converted into
common stock of the Company, $.001 par value per
share ("Common Stock"), upon the terms hereof and
upon the terms of the Articles of Amendment to
Articles of Incorporation - Certificate of
Designations, Preferences, Limitations and Relative
Rights of 1998 Series D Convertible Preferred Stock
of American Biomed, Inc., attached hereto as Exhibit
A (the "Series D Articles"). The price per Series D
Share is US$10.00. The aggregate number of Series D
Shares to be issued and sold by the Company is sixty
thousand Series D Shares, for an aggregate purchase
price of six hundred thousand United States dollars.
(ii) At each additional Closing (if any) (each, an
"Additional Closing") as further described in Section
4(1) below, shares of the Company's Series E
Convertible Preferred Stock (the "Series E Shares"),
which may be converted into Common Stock upon the
terms hereof and upon the terms of the Articles of
Amendment to Articles of Incorporation - Certificate
of Designations, Preferences, Limitations and
Relative Rights of 1998 Series E Convertible
Preferred Stock of American Biomed, Inc., attached
hereto as Exhibit B (the "Series E Articles"). The
price per Series E Share is US$10.00. The minimum
number of Series E Shares to be issued and sold by
the Company is two hundred thousand Series E Shares,
and the maximum number of Series
2
E Shares to be issued and sold by the Company is five
hundred thousand Series E Shares, all in accordance
with the terms hereof.
(iii) At each Closing, as additional consideration for
Buyer's purchase of the Preferred Shares (defined
below) a warrant (each a "Warrant" and collectively
the "Warrants") to purchase Common Stock at a
purchase price equal to one hundred twenty-five
percent (125%) of the closing bid price for the
Common Stock on the date of such Closing, which
Warrants must be exercised if at all within three (3)
years after the date of issuance. The Warrants shall
be substantially in the form attached hereto as
Exhibit E. The number of shares into which each
Warrant shall be exercisable shall be equal to the
number of Preferred Shares purchased at such Closing.
The Common Stock into which the Series D Shares and the Series E Shares
may (in accordance with the terms of the Series D Articles and the Series E
Articles, respectively) be convertible shall be collectively referred to herein
as the "Conversion Shares." The Common Stock received upon exercise of the
Warrants shall be referred to as the "Warrant Shares." Certain shares of Common
Stock may (at the Company's option as described in the Series D Articles or the
Series E Articles, as applicable) be issued to the Buyer in payment of dividends
(the "Dividend Shares"). Together the Series D Shares and the Series E Shares
may be referred to herein as the "Preferred Shares." The Preferred Shares, the
Conversion Shares, the Warrant Shares and the Dividend Shares (if any) may be
collectively referred to herein as the "Securities." Together the Series D
Articles and the Series E Articles may be referred to herein as the "Articles of
Amendment."
C. Contemporaneously with the execution and delivery of this Agreement,
the parties hereto are executing and delivering a Registration Rights Agreement
(the "Registration Rights Agreement") substantially in the form of Exhibit C
attached hereto pursuant to which the Company has agreed to provide certain
registration rights under the 1933 Act and the rules and regulations promulgated
thereunder, and applicable state securities laws.
AGREEMENTS
NOW, THEREFORE, in consideration of their respective promises contained
herein and other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged by the parties, the Company and the Buyer hereby
agree as follows:
1. PURCHASE AND SALE OF SECURITIES.
a. Purchase. The Buyer hereby agrees to purchase from the Company, and
the Company agrees to sell to the Buyer, 60,000 Series D Shares at the First
Closing, and at each Additional Closing, the number of Series E Shares described
in Section 4(1) below. The purchase price for the Preferred Shares purchased at
each Closing shall be as specified in Recitals B(i) and B(ii) above (with
respect to each Closing, the "Purchase Price").
2
3
b. The Closings. The date of the First Closing shall be April 29, 1998,
and the date of each Additional Closing (if any) shall be as specified in
Section 4(l) below, or, in each case on such earlier or later date as is
mutually agreed to in writing by the Company and the Buyer. The Purchase Price
for the Securities being purchased at each Closing shall be delivered to the
Escrow Agent (as defined in the Escrow Agreement substantially in the form of
Exhibit D attached hereto (the "Escrow Agreement")) on behalf of the Company on
or before the date specified herein for such Closing. At each Closing, the
Company shall deliver certificates representing the Preferred Shares and the
Warrants being sold at such Closing, duly issued and executed by the authorized
officers on behalf of the Company, to the Escrow Agent (as defined in the Escrow
Agreement) on behalf of the Buyer.
c. Form of Payment. The Buyer shall pay the Purchase Price for the
Preferred Shares and Warrants purchased at each Closing by wire transfer of
immediately available funds in United States Dollars, to be deposited into the
Escrow Account as defined in the Escrow Agreement, against delivery to the
Escrow Agent of duly executed Preferred Shares and Warrants being purchased by
the Buyer hereunder at such Closing. The Escrow Agent shall be responsible for
delivery of the Purchase Price to the Company and the Preferred Shares to the
Buyer in accordance with the terms of the Escrow Agreement and with the
instructions of the said parties.
2. BUYER'S REPRESENTATIONS AND WARRANTIES.
The Buyer understands, agrees with, and represents and warrants to the
Company with respect to its purchase hereunder, that:
a. Investment Purposes; Compliance With 1933 Act. The Buyer is
purchasing the Securities for its own account for investment only and not with a
view towards, or in connection with, the public sale or distribution thereof,
except pursuant to sales registered under or exempt from the 0000 Xxx. The Buyer
is not purchasing the Securities for the purpose of covering short sale
positions in the Common Stock established on or prior to the date of the
relevant Closing. The Buyer agrees to offer, sell or otherwise transfer the
Securities only (i) in accordance with the terms of this Agreement and the
Articles of Amendment, as applicable, and (ii) pursuant to registration under
the 1933 Act or to an exemption from registration under the 1933 Act and any
other applicable securities laws. The Buyer does not by its representations
contained in this Section 2(a) agree to hold the Securities for any minimum or
other specific term and reserves the right to dispose of the Securities at any
time pursuant to a registration statement or in accordance with an exemption
from registration under the 1933 Act, in all cases in accordance with applicable
state and federal securities laws. The Buyer understands that it shall be a
condition to the issuance of the Conversion Shares, the Warrant Shares and the
Dividend Shares (if any) that the Conversion Shares, the Warrant Shares and the
Dividend Shares (if any) be and are subject to the representations set forth in
this Section 2(a).
b. Accredited Investor Status. The Buyer is an "accredited investor" as
that term is defined in Rule 501 (a) of Regulation D. The Buyer has such
knowledge and experience in financial
3
4
and business matters that it is capable of evaluating the merits and risks of an
investment made pursuant to this Agreement. The Buyer is aware that it may be
required to bear the economic risk of an investment made pursuant to this
Agreement for an indefinite period of time, and is able to bear such risk for an
indefinite period.
c. Reliance on Exemptions. The Buyer understands the Securities are
being offered and sold to it in reliance on specific exemptions from the
registration requirements of the applicable United States federal and state
securities laws and that the Company is relying upon the truth and accuracy of,
and the Buyer's compliance with, the representations, warranties,
acknowledgments, understandings, agreements and covenants of the Buyer set forth
herein in order to determine the availability of such exemptions and the
eligibility of the Buyer to acquire the Securities.
d. Information. The Buyer and its advisors, if any, have been furnished
with all materials relating to the business, finances and operations of the
Company and materials relating to the offer and sale of the Securities which
have been requested by the Buyer, and specifically (but without limitation) the
Company's 1997 Form 10-K as filed with the SEC for the fiscal year ended
December 31, 1997 (the "1997 10-K"). The Buyer and its advisors, if any, have
been afforded the opportunity to ask all such questions of the Company as they
have in their discretion deemed advisable. The Buyer understands that its
investment in the Securities involves a high degree of risk. The Buyer has
sought such accounting, legal and tax advice as it has considered necessary to
an informed investment decision with respect to the investment made pursuant to
this Agreement.
e. No Government Review. The Buyer understands that no United States
federal or state agency or any other government or governmental agency has
passed on or made any recommendation or endorsement of the Securities or the
fairness or suitability of the investment in the Securities, nor have such
authorities passed upon or endorsed the merits of the offering of the
Securities.
f. Transfer or Resale. The Buyer understands that: (i) except as
provided in the Registration Rights Agreement, the Securities have not been and
are not being registered under the 1933 Act or any state securities laws, and
may not be offered for sale, sold, assigned or transferred unless either (a)
subsequently registered thereunder or (b) the Buyer shall have delivered to the
Company an opinion by counsel reasonably satisfactory to the Company, in form,
scope and substance reasonably satisfactory to the Company, to the effect that
the securities to be sold, assigned or transferred may be sold, assigned or
transferred pursuant to an exemption from such registration, (ii) any sale of
such securities made in reliance on Rule 144 (as hereafter defined) may be made
only in accordance with the terms of Rule 144 and further, if Rule 144 is not
applicable, any resale of such securities under circumstances in which the
seller (or the person though whom the sale is made) may be deemed to be an
underwriter (as that term is defined in the 0000 Xxx) may require compliance
with some other exemption under the 1933 Act or the rules and regulations of the
SEC thereunder, and (iii) neither the Company nor any other person is under any
obligation to register such securities under the 1933 Act or any state
securities laws or to comply with the terms and
4
5
conditions of any exemption thereunder (in each case, other than pursuant to
this Agreement or the Registration Rights Agreement).
g. Legend. The Buyer understands that the Preferred Shares, and until
such time as the Conversion Shares, the Warrant Shares and the Dividend Shares
(if any) (collectively, the "Registrable Securities"), have been registered
under the 1933 Act as contemplated by the Registration Rights Agreement or
otherwise may be sold by the Buyer pursuant to Rule 144 (as amended, or any
applicable rule which operates to replace said Rule) promulgated under the 1933
Act ("Rule 144"), the stock certificates representing the Registrable Securities
will bear a restrictive legend (the "Legend") in substantially the following
form:
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE "ACT"), OR APPLICABLE STATE SECURITIES LAWS
(COLLECTIVELY, THE "LAWS"). THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND
MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF
EITHER (I) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE
LAWS, OR (II) AN OPINION OF COUNSEL PROVIDED TO THE ISSUER IN FORM, SUBSTANCE
AND SCOPE REASONABLY ACCEPTABLE TO THE ISSUER TO THE EFFECT THAT REGISTRATION IS
NOT REQUIRED UNDER THE LAWS DUE TO AN AVAILABLE EXCEPTION TO OR EXEMPTION FROM
THE REGISTRATION REQUIREMENTS OF THE LAWS.
The Legend shall be removed and the Company will issue certificates
without the Legend to the holder of the applicable Preferred Shares or any
Registrable Securities upon which the Legend is stamped, in accordance with
Section 5(b).
h. Authorization; Enforcement. This Agreement, the Registration Rights
Agreement and the Escrow Agreement have been duly and validly authorized,
executed and delivered by the Buyer and are each and collectively valid and
binding agreements of the Buyer enforceable in accordance with their terms,
subject as to enforceability to general principles of equity and to bankruptcy,
insolvency, moratorium, and other similar laws affecting the enforcement of
creditors' rights generally. Buyer (and Buyer's counsel) has examined this
Agreement and is satisfied in its sole discretion that this Agreement and the
accompanying Exhibits, Schedules and the Addenda, if any, are in accordance with
Regulation D and are effective to accomplish the purposes set forth herein and
therein.
3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.
The Company understands, agrees with, and represents and warrants to
the Buyer that:
a. Organization and Qualification: Reporting Company Status. The
Company and its subsidiaries are corporations duly organized and existing in
good standing under the laws of the respective jurisdictions in which they are
incorporated, except as would not have a Material Adverse
5
6
Effect (as defined below), and have the requisite corporate power to own their
properties and to carry on their business as now being conducted. Each of the
Company and its subsidiaries is duly qualified as a foreign corporation to do
business and is in good standing in every jurisdiction in which the nature of
the business conducted by it makes such qualification necessary and where the
failure so to qualify would have a Material Adverse Effect. "Material Adverse
Effect" means any material adverse effect on the operations, properties or
financial condition of the Company and its subsidiaries taken as a whole. The
Company has registered its Common Stock pursuant to Section 12 of the 1934 Act,
and the Common Stock is eligible for trading on the OTC Bulletin Board Market.
The Company has received no notice, either written or oral, with respect to the
continued eligibility of the Common Stock for such eligibility for trading, and
the Company has maintained all applicable requirements for the continuation of
such eligibility for trading, and the Company does not reasonably anticipate
that the Common Stock will be declared ineligible to trade on the OTC Bulletin
Board Market for the foreseeable future. Seller shall use its best efforts to
continue to keep its stock eligible for trading on the OTC Bulletin Board Market
or a comparable stock market or exchange. The Company has complied with all
applicable requirements (if any) of the National Association of Securities
Dealers and the OTC Bulletin Board Market with respect to the issuance of the
Securities.
b. Authorization; Enforcement. (i) The Company has the requisite
corporate power and authority to enter into and perform this Agreement, the
Registration Rights Agreement and the Escrow Agreement, to issue and sell the
Preferred Shares and the Registrable Securities in accordance with the terms
hereof, and to perform its obligations under the Series D Articles and the
Series E Articles in accordance with the requirements of the same, (ii) the
execution, delivery and performance of this Agreement, the Registration Rights
Agreement and the Escrow Agreement by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by
the Company's Board of Directors and no further consent or authorization of the
Company, its Board of Directors, or its stockholders is required, (iii) this
Agreement, the Registration Rights Agreement, the Escrow Agreement and, on the
date of the applicable Closing, the Preferred Shares and Warrants sold at such
Closing, have been duly and validly authorized, executed and delivered by the
Company, (iv) the Series D Articles and the Series E Articles have been duly
authorized by the Company's Board of Directors to be filed with the Secretary of
State for the State of Delaware, and the Series D Articles and the Series E
Articles will be filed with the Secretary of State for the State of Delaware
prior to the date of the First Closing, and (v) this Agreement, the Registration
Rights Agreement and the Escrow Agreement constitute the valid and binding
obligations of the Company enforceable against the Company in accordance with
their respective terms, except as such enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting, generally, the enforcement of creditors'
rights and remedies or by other equitable principles of general application. The
Company (and its legal counsel) has examined this Agreement and is satisfied in
its sole discretion that this Agreement and the accompanying Exhibits, Schedules
and the Addenda, if any, are in accordance with Regulation D and are effective
to accomplish the purposes set forth herein and therein.
6
7
c. Capitalization. As of March 31, 1998, the authorized capital stock
of the Company consists of 50,000,000 shares of Common Stock of which 22,308,566
shares were issued and outstanding; as of March 31, 1998, the authorized
preferred stock of the Company consists of 2,000,000 shares, of which 1,290
shares of Series A, 300 shares of Series B, and 83 shares of Series C preferred
stock were issued and outstanding. All of such outstanding shares have been
validly issued and are fully paid and nonassessable. Except as disclosed in
Schedule 3(c), no shares of Common Stock or Preferred Stock are subject to
preemptive rights or any other similar rights or any liens or encumbrances.
Except as disclosed in Schedule 3(c) attached and in the 1997 10-K, as of the
effective date of this Agreement, (i) there are no outstanding options,
warrants, scrip, rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible into, any shares of
capital stock of the Company or any of its subsidiaries, or arrangements by
which the Company or any of its subsidiaries is or may become bound to issue
additional shares of capital stock of the Company or any of its subsidiaries,
(ii) there are no outstanding debt securities, and (iii) there are no agreements
or arrangements under which the Company or any of its subsidiaries is obligated
to register the sale of any of its or their securities under the 1933 Act
(except as provided herein and in the Registration Rights Agreement). If
requested by the Buyer, the Company has furnished to the Buyer, and the Buyer
acknowledges receipt of same by its signature hereafter, true and correct copies
of the Company's Certificate of Incorporation, as amended, as in effect on the
date hereof ("Certificate of Incorporation"), and the Company's Bylaws, as in
effect on the date hereof (the "Bylaws").
d. Issuance of Securities. The Series D Shares, the Series E Shares and
the Registrable Securities are all duly authorized and reserved for issuance,
and in all cases upon issuance shall be validly issued, fully paid and
non-assessable, free from all taxes, liens and charges with respect to the issue
thereof, and will not be subject to preemptive rights or other similar rights of
stockholders of the Company.
e. Acknowledgment Regarding Buyer's Purchase of the Securities. The
Company acknowledges and agrees that the Buyer is not acting as financial
advisor to or fiduciary of the Company (or in any similar capacity with respect
to this Agreement or the transactions contemplated hereby), that this Agreement
and the transactions contemplated hereby, and the relationship between the Buyer
and the Company, are and will be considered "arms-length" notwithstanding any
other or prior agreements or nexus between the Buyer and the Company, whether or
not disclosed, and that any statement made by the Buyer, or any of its
representatives or agents, in connection with this Agreement and the
transactions contemplated hereby is not advice or a recommendation, is merely
incidental to the Buyer's purchase of the Securities and has not been relied
upon in any way by the Company, its officers or directors. The Company further
represents to the Buyer that the Company's decision to enter into this Agreement
and the transactions contemplated hereby have been based solely upon an
independent evaluation by the Company, its officers and directors.
7
8
f. No Integrated Offering. Neither the Company, nor any of its
affiliates, nor any person acting on its or their behalf, has directly or
indirectly made any offers or sales of any security or solicited any offers to
buy any security under circumstances which would prevent the parties hereto from
consummating the transactions contemplated hereby pursuant to an exemption from
registration under the 1933 Act and specifically in accordance with the
provisions of Regulation D. The transactions contemplated hereby are exempt from
the registration requirements of the 1933 Act, assuming the accuracy of the
representations and warranties contained herein of the Buyer.
g. No Conflicts. The execution, delivery and performance of this
Agreement by the Company and the consummation by the Company of the transactions
contemplated hereby will not (i) result in a violation of the Certificate of
Incorporation or Bylaws or (ii) conflict with, or constitute a default (or an
event which with notice or lapse of time or both would become a default) under,
or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Company or
any of its subsidiaries is a party, or result in a violation of any law, rule,
regulation, order, judgment or decree (including federal and state securities
laws and regulations) applicable to the Company or any of its subsidiaries or by
which any property or asset of the Company or any of its subsidiaries is bound
or affected (except for such conflicts, defaults, terminations, amendments,
accelerations, cancellations and violations as would not, individually or in the
aggregate, have a Material Adverse Effect). Neither the Company nor any of its
subsidiaries is in violation of its Certificate of Incorporation or other
organizational documents, and neither the Company nor any of its/subsidiaries is
in default (and no event has occurred which, with notice or lapse of time or
both, would put the Company or any of its subsidiaries in default) under, nor
has there occurred any event giving others (with notice or lapse of time or
both) any rights of termination, amendment, acceleration or cancellation of, any
agreement, indenture or instrument to which the Company or any of its
subsidiaries is a party, except for possible defaults or rights as would not, in
the aggregate or individually, have a Material Adverse Effect. The business of
the Company and its subsidiaries is not being conducted, and shall not be
conducted so long as the Buyer owns any of the Securities, in violation of any
law, ordinance or regulation of any governmental entity, except for possible
violations which neither singly or in the aggregate would have a Material
Adverse Effect. Except as specifically contemplated by this Agreement and as
required under the 1933 Act and any applicable state securities laws, the
Company is not required to obtain any consent, authorization or order of, or
make any filing or registration with, any court or governmental agency in order
for it to execute, deliver or perform any of its obligations under this
Agreement, the Registration Rights Agreement or the Escrow Agreement in
accordance with the terms hereof and thereof, or to perform its obligations with
respect to the Preferred Shares exactly as described in the applicable Articles
of Amendment.
h. SEC Documents; Financial Statements. Since at least April 1, 1997,
the Company has timely filed all reports, schedules, forms, statements and other
documents required to be filed by it with the SEC pursuant to the reporting
requirements of the Securities Exchange Act of 1934, as amended (the "1934 Act")
(all of the foregoing filed prior to the date hereof and all exhibits included
therein and financial statements and schedules hereto and documents (other than
exhibits) incorporated by reference therein, being hereinafter referred to as
the "SEC Documents"). The Company has
8
9
delivered to the Buyer as requested by the Buyer true and complete copies of the
SEC Documents, except for such exhibits, schedules and incorporated documents.
As of their respective dates, the SEC Documents complied in all material
respects with the requirements of the 1934 Act and the rules and regulations of
the SEC promulgated thereunder applicable to the SEC Documents, and none of the
SEC Documents, at the time they were filed with the SEC, contained any untrue
statement of a material fact or omitted to state a material fact required to be
stated therein or necessary in order to make the statements therein, in light of
the circumstances under which they were made, not misleading. As of their
respective dates, the financial statements of the Company included in the SEC
Documents complied as to form in all material respects with applicable
accounting requirements and the published rules and regulations of the SEC with
respect thereto. Such financial statements have been prepared in accordance with
generally accepted accounting principles, consistently applied, during the
periods involved (except (i) as may be otherwise indicated in such financial
statements or the notes thereto, or (ii) in the case of unaudited interim
statements, to the extent they may exclude footnotes or may be condensed or
summary statements) and fairly present in all material respects the financial
position of the Company as of the dates thereof and the results of its
operations and cash flows for the periods then ended (subject, in the case of
unaudited statements, to normal year-end audit adjustments). No other
information provided by or on behalf of the Company to the Buyer (including the
information referred to in Section 2(d) of this Agreement) contains any untrue
statement of a material fact or omits to state any material fact necessary in
order to make the statements therein, in the light of the circumstance under
which they are or were made, not misleading. Except as set forth in the
financial statements of the Company included in the SEC Documents, the Company
has no liabilities, contingent or otherwise, other than (i) liabilities incurred
in the ordinary course of business subsequent to the date of such financial
statements and (ii) obligations under contracts and commitments incurred in the
ordinary course of business and not required under generally accepted accounting
principles to be reflected in such financial statements, in each case of clause
(i) and (ii) next above which, individually or in the aggregate, are not
material to the financial condition, business, operations, properties, operating
results or prospects of the Company. The SEC Documents contain a complete and
accurate list of all material undischarged written and oral contracts,
agreements, leases or other instruments to which the Company or any subsidiary
is a party or by which the Company or any subsidiary is subject (each a
"Contract"). None of the Company, its subsidiaries or, to the best of the
Company's knowledge, any of the other parties thereto, is in breach or violation
of any Contract, which breach or violation would have a Material Adverse Effect.
No event, occurrence or condition exists which, with the lapse of time, the
giving of notice, or both, or the happening of any further event or condition,
would become a default by the Company or its subsidiaries thereunder which would
have a Material Adverse Effect.
i. Absence of Certain Changes. Except as disclosed in the Company's
1997 10-K, since December 31, 1997, there has been no material adverse change
and no material adverse development in the business, properties, operation,
financial condition, results of operations or prospects of the Company. The
Company has not taken any steps, and does not currently have any reasonable
expectation of taking any steps, to seek protection pursuant to any bankruptcy
law nor does the Company have any knowledge that its creditors intend to
initiate involuntary bankruptcy
9
10
proceedings. The Company shall, at least until Buyer no longer holds any of the
Securities, maintain its corporate existence in good standing and shall pay all
taxes when due except for taxes it reasonably disputes.
j. Absence of Litigation. Except as set forth in the 1997 10-K, there
is no action, suit, proceeding, inquiry or investigation before or by any court,
public board or body pending or, to the knowledge of the Company, threatened
against or affecting the Company, wherein an unfavorable decision, ruling or
finding would have a Material Adverse Effect or which would adversely affect the
validity or enforceability of, or the authority or ability of the Company to
perform its obligations under, this Agreement or any of the documents
contemplated herein.
k. Foreign Corrupt Practices. Neither the Company nor any of its
subsidiaries, nor any officer, director or other person acting on behalf of the
Company or any subsidiary has, in the course of his actions for or on behalf of
the Company, used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expense relating to political activity, made any
direct or indirect unlawful payment to any foreign or domestic government
official or employee from corporate funds; violated or is in violation of any
provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or made
any bribe, rebate, payoff, influence payment, kickback or other unlawful payment
to any foreign or domestic government official or employee.
l. Acknowledgment of Dilution. The number of Conversion Shares issuable
upon conversion of the Preferred Shares may increase substantially in certain
circumstances, including the circumstance wherein the trading price of the
Common Stock declines. The Company's executive officers and directors have
studied and fully understand the nature of the securities being sold hereunder
and recognize they have a potential dilutive effect. The board of directors of
the Company has concluded in its good faith business judgment that such issuance
is in the best interests of the Company. The Company acknowledges that its
obligation to issue Conversion Shares upon conversion of the Preferred Shares
and Warrant Shares upon exercise of the Warrants is binding upon it and
enforceable regardless of the dilution that such issuance may have on the
ownership interests of other stockholders.
m. Eligibility to File Registration Statement. The Company is currently
eligible to file a registration statement with the SEC on Form S-3 under the
1933 Act.
4. COVENANTS.
a. Best Efforts. Each party shall use its best efforts timely to
satisfy each of the conditions to be satisfied by it as provided in Sections 6
and 7 of this Agreement.
b. Securities Laws. The Company agrees to timely file a Form D (and any
equivalent form required by applicable state law) with respect to the Securities
if and as required under Regulation D and applicable state securities laws and
to provide a copy thereof to the Buyer promptly after such filing. The Company
shall, on or
10
11
before the date of the First Closing and on or before the date of each
Additional Closing, as applicable, take such action as is necessary to sell the
Securities being sold to the Buyer on each such date under applicable securities
laws of the United States, and shall if specifically so requested provide
evidence of any such action so taken to the Buyer on or prior to the First
Closing Date or each Additional Closing date, as applicable.
c. Reporting Status. So long as the Buyer beneficially owns any of the
Securities, the Company shall file all reports required to be filed with the SEC
pursuant to the 1934 Act, and the Company shall not terminate its status as an
issuer required to file reports under the 1934 Act even if the 1934 Act or the
rules and regulations hereunder would permit such termination.
d. Use of Proceeds. The Company will use the proceeds from the sale of
the Securities to pay off certain outstanding obligations of the Company and for
the Company's internal working capital purposes, including costs and expenses of
the Company's business operations, and to the extent deemed advisable by the
Company, for the purchase of new technologies for use by the Company and its
subsidiaries, and for the purchase of additional subsidiaries and the
development and marketing of their technologies.
e. Financial Information. At the request of the Buyer, until such time
as the Buyer no longer beneficially owns or is entitled to purchase Preferred
Shares, the Company agrees to send the following reports to the Buyer: (i) after
filing with the SEC, a copy of each of its Annual Reports on Form 10-K, its
quarterly Reports on Form 10-Q, and any reports filed on Form 8-K; and (ii) as
soon as practicable after release thereof, copies of all press releases issued
by the Company or any of its subsidiaries.
f. Reservation of Shares. The Company shall at all times have
authorized, and reserved for the purpose of issuance, a sufficient number of
shares of Common Stock to provide for the issuance of all of the Conversion
Shares and the Dividend Shares (if any). Prior to complete conversion of the
Preferred Shares, the Company shall not reduce the number of shares reserved for
issuance hereunder without the written consent of the Buyer except for a
reduction proportionate to a reverse stock split effected for a business purpose
other than affecting the requirements of this Section, which reverse stock split
affects all shares of Common Stock equally.
g. Listing. Upon the First Closing and upon each Additional Closing,
the Company shall promptly secure the listing of the Registrable Securities then
underlying the Preferred Shares purchased by the Buyer upon each national
securities exchange or automated quotation system, if any, upon which shares of
Common Stock are then listed (subject to official notice of issuance) and shall
maintain, so long as any other shares of Common Stock shall be so listed, such
listing of shares of Registrable Securities from time to time issued under the
terms of this Agreement and the Registration Rights Agreement. If at the
relevant time the Company's Common Stock trades on the OTC Bulletin Board
Market, then the Company shall take any steps necessary to ensure that the
Registrable Securities are eligible to trade on the OTC Bulletin Board Market.
The Company shall at all times comply in all respects with the Company's
reporting, filing and other obligations under the by-laws or rules of the
National Association of Securities Dealers and the OTC Bulletin Board
11
12
Market (and such other national exchange on which the Common Stock may be
listed, as applicable), if any.
h. Prospectus Delivery Requirement. The Buyer understands that the 1933
Act requires delivery of a prospectus relating to the Common Stock in connection
with any sale thereof pursuant to a registration statement under the 1933 Act
covering any resale by the Buyer of the Common Stock being sold, and the Buyer
shall comply with any applicable prospectus delivery requirements of the 1933
Act in connection with any such sale. The Company shall deliver a copy of the
required prospectus to the Buyer immediately upon registration of the
Registrable Securities.
i. (Intentionally Omitted).
j. Intentional Acts or Omissions. Neither party shall intentionally
perform any act which if performed, or omit to perform any act which if omitted
to be performed, would prevent or excuse the performance of this Agreement or
any of the transactions contemplated hereby.
k. No Shorting. As a material inducement for the Company to enter into
this Agreement, the Buyer represents that it has not as of the date hereof, and
covenants on behalf of itself and its affiliates that neither Buyer nor any
affiliate of Buyer will at any time in which the Buyer or any affiliate of the
Buyer beneficially owns any of the Securities, engage in any short sales of, or
hedging or arbitrage transactions with respect to, the Common Stock, or sell
"put" options or similar instruments with respect to the Common Stock.
1. Purchase of Series E Shares. Until the date which is twenty-four
(24) months from the date hereof, the Buyer agrees to purchase, and the Company
agrees to sell, in accordance with and subject to the terms of this Agreement
and the Series E Articles, a minimum of 200,000 Series E Shares and, at the
Company's option, up to a maximum of 500,000 Series E Shares, in each case in a
series of tranches, each of which tranches shall be for the purchase and sale of
a minimum of 12,500 Series E Shares and a maximum of 25,000 Series E Shares in
any given tranche.
No such tranche shall be closed before the date which is thirty (30)
days after the date on which the registration statement contemplated by the
Registration Rights Agreement and covering all of the Registrable Securities is
declared effective by the SEC and the Registrable Securities may thus be freely
sold by Buyer without restriction, and Buyer has been so informed in writing
(and any prospectus needed to sell such Registrable Securities has been
delivered to Buyer). The Series E Shares to be issued in each such tranche shall
be issued and sold upon the terms and conditions of this Agreement and the
Series E Articles. The obligations of the Company to sell and the Buyer to
purchase Series E Shares at each Additional Closing (each of which Additional
Closings (other than the first) shall occur no less than thirty (30) days after
the date of the previous Additional Closing), shall be contingent upon
satisfaction of the following conditions:
(i) The Company shall give the Buyer and the Escrow Agent ten (10)
days prior written notice of its intent to sell Series E
Shares;
12
13
(ii) On the date of each Additional Closing:
(a) The registration statement required to be filed under
the Registration Rights Agreement has been declared
effective by the SEC and is as of such date still
effective with respect to (i) all Conversion Shares
into which the Preferred Shares may be convertible,
(ii) all Warrant Shares receivable upon exercise of
the Warrants, and (iii) any Dividend Shares to be
issued in payment of dividends, such that all such
Conversion Shares, Warrant Shares and Dividend Shares
may be freely traded on the OTC Bulletin Board Market
by Buyer at any time after receipt thereof.
(b) Each of the representations and warranties of the
Company contained in this Agreement, the Registration
Rights Agreement and the Escrow Agreement (the
"Transaction Documents") shall be true and correct in
all material respects as if made on the date of such
Additional Closing, and the Company shall have
performed all of its obligations under the
Transaction Documents required to be performed by the
Company prior to the date of such Additional Closing.
(c) The average daily trading volume for the Common Stock
for the previous sixty (60) trading days must equal
or exceed 150,000 shares per trading day.
(d) The average daily share price for the Common Stock
for the ten (10) trading days prior thereto, must
equal or exceed $.45 per share.
(e) The number of shares issuable upon conversion of the
Series E Shares then being purchased, together with
the shares of Common Stock issued prior thereto
pursuant to the Transaction Documents and the
Articles of Amendment, shall not exceed twenty
percent (20%) of the outstanding shares of the
Company's Common Stock. This condition shall be
waived by the Buyer should the Company obtain any
required shareholder or other consent to the issuance
of more than twenty percent (20%) of the outstanding
shares of the Company's Common Stock prior to such
Additional Closing.
(f) No statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by any court or
governmental authority of competent jurisdiction or
any self-regulatory organization having authority
over the matters contemplated hereby which restricts
or prohibits the consummation of any of the
transactions contemplated by the Transaction
Documents or the Articles of Amendment.
13
14
If the Company does not sell to the Buyer, within the twenty-four (24)
month period specified in this Section 4(l), at least the minimum number of
Series E Shares and the corresponding number of Warrants to have been sold
pursuant to this Section 4(l), other than as a result of a breach of this
Agreement by the Buyer, then unless the Buyer agrees in writing to extend the
time in which the Company may sell Series E Shares to the Buyer, the Company
shall issue to the Buyer a warrant (a "Penalty Warrant") to purchase a number of
shares of Common Stock equal to the minimum number of Series E Shares to have
been sold less the number of Series E Shares actually sold to the Buyer. The
Penalty Warrant shall be exercisable if at all within three (3) years after
issuance at a price per share of Common Stock equal to the closing bid price of
the Common Stock on the date of the First Closing. The Penalty Warrant shall
contain both demand and "piggyback" registration rights. Thus, for example, if
the Buyer purchased 25,000 Series D Shares (fifty percent (50%) of the total
number of Series D Shares sold), and if the closing bid price for the Common
Stock on the date of the First Closing were US$1.00, and if the Company at the
end of the period which is twenty-four (24) months after the date of the First
Closing shall have sold the Buyer only 50,000 Series E Shares, then the Company
shall issue a Penalty Warrant with an exercise price per share of US$1.00 for
50,000 shares of Common Stock (the minimum number of Series E Shares to have
been sold to the Buyer would have been 100,000, or fifty percent (50%) of the
total 200,000 Series E Shares to have been sold).
Conversely, if the Buyer does not purchase all of its pro-rata portion
of the Series E Shares offered for sale by the Company (other than for a breach
of this Agreement by the Company or failure of the Company to meet the
conditions stated in Section 4(l)) when such Series E Shares are so offered for
sale in accordance with the terms of this Agreement, then at such time as the
Buyer refuses to purchase such Series E Shares being offered for sale, unless
waived by the Company, all Warrants previously issued to the Buyer, to the
extent not already exercised by the Buyer, shall be null and void.
m. Restriction on Below Market Issuance of Securities. Until the date
which is twenty-four (24) months from the date hereof, the Company shall not
issue or agree to issue {other than (i) to the Buyer or other buyers pursuant to
the transactions contemplated herein, (ii) pursuant to any employee stock option
plan or employee stock purchase plan of the Company in effect on Xxxxx 00, 0000,
(xxx) pursuant to any existing security, option, warrant, scrip, call or
commitment or right in each case as disclosed on Schedule 3(c) hereof, or (iv)
with the consent of the Buyer, not to be unreasonably withheld} any equity
securities of the Company (or any security convertible into or exercisable or
exchangeable, directly or indirectly, for equity securities of the Company) or
debt securities of the Company if such securities are issued at a price (or
provide for a conversion, exercise or exchange price) which may be less than the
current market price for the Common Stock on the date of issuance (in the case
of Common Stock) or the date of conversion, exercise or exchange (in the case of
securities convertible into or exercisable or exchangeable, directly or
indirectly, for Common Stock). Except as provided with respect to the
transactions contemplated herein and in subsections (i), (ii), (iii), or (iv)
above of this Section 4(m), the Company shall not grant any additional so-called
"registration rights."
14
15
5. LEGEND AND TRANSFER INSTRUCTIONS.
a. Transfer Agent Instructions. The Company shall instruct its transfer
agent to issue certificates, registered in the name of the Buyer or its nominee,
for the Conversion Shares, the Warrant Shares and the Dividend Shares (if any)
in accordance with the terms of the applicable Articles of Amendment and in such
amounts as specified from time to time by the Buyer to the Company, upon
conversion of the Preferred Shares and exercise of the Warrants. All such
certificates shall bear the restrictive legend specified in Section 2(g) of this
Agreement only to the extent required by applicable law and as specified in the
Transaction Documents. The Company warrants that no instruction other than such
instructions referred to in this Section 5, and stop transfer instructions to
give effect to Section 2(f) hereof in the case of the Conversion Shares and the
Dividend Shares (if any) prior to the registration of same under the 1933 Act,
will be given by the Company to its transfer agent and that the Conversion
Shares, the Warrant Shares and the Dividend Shares (if any) shall otherwise be
freely transferable on the books and records of the Company as and to the extent
permitted by applicable law and provided by this Agreement and the Registration
Rights Agreement. Nothing in this Section shall affect in any way the Buyer's
obligations and agreement to comply with all applicable securities laws upon
resale of the Conversion Shares, the Warrant Shares and/or the Dividend Shares
(if any). If the Buyer (x) provides the Company with an opinion of counsel
reasonably satisfactory to Company, that is reasonably satisfactory in form,
substance and scope to the Company, that registration by the Buyer of the
Preferred Shares, the Conversion Shares, the Warrant Shares and/or the Dividend
Shares (if any) is not required under the 1933 Act, or (y) transfers Securities
to an affiliate which is an accredited investor (in accordance with the
provisions of this Agreement) or in compliance with Rule 144, then in either
instance the Company shall permit the said transfer, and if applicable promptly
(and in all events within two (2) trading days after receipt by the Company of
each of the original documents and things to be delivered by the Buyer to effect
a conversion of the applicable Preferred Shares) instruct its transfer agent to
issue one or more certificates in such name and in such denominations as
specified by the Buyer
b. Removal of Legends. The Legend shall be removed and the Company
shall issue a certificate without such Legend to the holder of any Security upon
which it is stamped, and a certificate for a security shall be originally issued
without the Legend, if, unless otherwise required by state securities laws, (x)
the sale of such Security is registered under the 1933 Act, or (y) such holder
provides the Company with an opinion by counsel reasonably satisfactory to the
Company, that is in form, substance and scope reasonably satisfactory to the
Company, to the effect that a public sale or transfer of such Security may be
made without registration under the 1933 Act or (z) such holder provides the
Company with assurances reasonably satisfactory to the Company and its counsel,
that such Security can be sold pursuant to Rule 144. The Buyer agrees that its
sale of all Securities, including those represented by a certificate(s) from
which the Legend has been removed, or which were originally issued without the
Legend, shall be made only pursuant to an effective registration statement (and
to deliver a prospectus in connection with such sale) or in compliance with an
exemption from the registration requirements of the 1933 Act. In the event the
Legend is removed from any Security or any Security is issued without the Legend
and thereafter the
15
16
effectiveness of a registration statement covering the sales of such Security is
suspended or the Company determines that a supplement or amendment thereto is
required by applicable securities laws, then upon reasonable advance notice to
the holder of such Security, the Company shall be entitled to require that the
Legend be placed upon any such Security which cannot then be sold pursuant to an
effective registration statement or Rule 144 or with respect to which the
opinion referred to in clause (y) next above has not been rendered, which Legend
shall be removed when such Security may be sold pursuant to an effective
registration statement or Rule 144 (or such holder provides the opinion with
respect thereto described in clause (y) next above.
c. Conversion of Preferred Shares. The Buyer shall have the right to
convert the Preferred Shares sold hereunder by delivering via facsimile an
executed and completed Notice of Conversion (as defined in the Articles of
Amendment) to the Company and delivering within two (2) business days thereafter
the original Notice of Conversion and the certificate representing the Preferred
Shares being converted by express courier to the Company. Each date on which a
Notice of Conversion is telecopied to the Company in accordance with the
provisions hereof shall be deemed a "Conversion Date." The Company will transmit
a certificate or certificates (collectively the "Certificate") representing the
shares of Common Stock issuable upon conversion of any Preferred Shares
converted pursuant to such Notice of Conversion (along with a replacement
certificate representing the number of Preferred Shares not so converted) to the
Buyer via express courier, within three (3) business days after the relevant
Conversion Date (the third business day after the relevant Conversion Date shall
be referred to hereinafter as the "Deadline"). With the mutual agreement of the
Company and the Buyer, the Company or a third party may (until and unless the
Buyer in a particular instance requests otherwise) hold the Preferred Shares in
trust, such that, to effect a conversion of the Preferred Shares, the Buyer
shall deliver to the Company via courier only the original Notice of Conversion
as described in this Section and the Company and the Buyer shall keep a record
of the number of Preferred Shares so converted. If either the Company or a third
party holds the certificates representing the Preferred Shares in trust as
described in the preceding sentence, the Company will deliver the Certificates
directly to the Buyer via express courier on or before the Deadline.
d. Injunctive Relief for Breach. The Company acknowledges that the
remedy at law for a breach of its obligations under Sections 5(a), 5(b) and 5(c)
above will cause irreparable harm to the Buyer by vitiating the intent and
purpose of the transactions contemplated hereby. Accordingly the Company agrees
that the remedy at law for a breach of its obligations under such Sections would
be inadequate and agrees, in the event of a breach or threatened breach by the
Company of the provisions of such Sections, the Buyer shall be entitled, in
addition to all other remedies at law or in equity (including without limitation
those remedies specified in Section 5(e) below), to an injunction restraining
any breach and requiring immediate issuance and transfer, without the necessity
of showing economic loss and without any bond or other security being required.
e. Liquidated Damages for Non-Delivery of Certificates. In addition to
the provisions of Section 5(d) above, the Company understands and agrees that a
delay in the issuance of the Certificates beyond the Deadline could result in
economic loss and other damages to the Buyer. As
16
17
partial compensation to the Buyer for such loss, the Company agrees to pay
liquidated damages (and which the Company acknowledges is not a penalty) to the
Buyer for issuance and delivery of the Certificates after the Deadline, in
accordance with the following schedule (where "No. Business Days Late" is
defined as the number of business days beyond seven (7) business days from the
date of delivery by the Buyer to the Company of a facsimile Notice of Conversion
(or, if later, from the date on which all other necessary documentation duly
executed and in proper form required for conversion of Preferred Shares as
described in this Agreement, including the original Notice of Conversion and the
original certificate representing the Preferred Shares to be converted, all in
accordance with this Agreement only if such necessary documentation has not been
delivered to the Company within the three (3) business day period after the
facsimile delivery to the Company of the Notice of Conversion required in this
Agreement)):
No. Business Days Late Liquidated Damages
---------------------- ------------------
(in US$)
1 $300
2 $400
3 $500
4 $600
5 $700
6 $800
7 $900
8 $1,000
9 $1,000
10 $1,500
11+ $1,500 + $500 for
each Business Day Late
beyond 11 days
The Company shall pay the Buyer any liquidated damages incurred as
called for under this Section 5(e) by certified or cashier's check upon the
earlier of (i) issuance of the Certificates to the Buyer or (ii) each monthly
anniversary of the receipt by the Company of the Buyer's Notice of Conversion.
Nothing herein shall limit the Buyer's right to pursue actual damages for the
Company's failure to issue and deliver the Certificates to the Buyer in
accordance with the terms of this Agreement or for breach by the Company of this
Agreement.
6. CONDITIONS TO THE COMPANY'S OBLIGATION TO SELL.
The obligation of the Company hereunder to sell Preferred Shares at the
applicable Closing is subject to the satisfaction, on or before the date of the
applicable Closing as described herein, of each of the following conditions,
provided that these conditions are for the Company's sole benefit and may be
waived by the Company at any time in its sole discretion:
17
18
a. The parties shall have executed this Agreement, the Registration
Rights Agreement and the Escrow Agreement, and the parties shall have delivered
the respective documents or signature pages thereof (via facsimile or otherwise
as permitted in the Escrow Agreement) to the Escrow Agent.
b. The Buyer shall have delivered to the Escrow Agent on behalf of the
Company the Purchase Price in full for the Series D Shares purchased at the
First Closing, or the Purchase Price in full for the Series E Shares being
purchased at each Additional Closing, as applicable, by wire transfer of
immediately available funds pursuant to the wiring instructions provided by the
Escrow Agent.
c. The representations and warranties of the Buyer shall be true and
correct in all material respects as of the date made and as of the date of the
applicable Closing as though made at that time (except for representations and
warranties that speak as of a specific date), and the Buyer shall have
performed, satisfied and complied in all material respects with the covenants,
agreements and conditions required by this Agreement to be performed, satisfied
or complied with by the Buyer at or prior to the date of the applicable Closing.
d. No statute, rule, regulation, executive order, decree, ruling or
injunction shall have been enacted, entered, promulgated or endorsed by any
court or governmental authority of competent jurisdiction or any self regulatory
organization having authority over the matters contemplated hereby which
restricts or prohibits the consummation of any of the transactions contemplated
herein.
7. CONDITIONS TO THE BUYER'S OBLIGATION TO PURCHASE.
The obligation of the Buyer to purchase Preferred Shares is subject to
the satisfaction, on or before the date of the applicable Closing, of each of
the following conditions, provided that these conditions are for the sole
benefit of the Buyer and may be waived by the Buyer at any time in its sole
discretion:
a. The Series D Articles and the Series E Articles shall have been duly
authorized and filed with the Secretary of State of the state of Delaware; the
parties shall have executed this Agreement, the Registration Rights Agreement
and the Escrow Agreement, and the parties shall have delivered the respective
documents or signature pages thereof (via facsimile or otherwise as permitted in
the Escrow Agreement), to the Escrow Agent on behalf of each other.
b. The representations and warranties of the Company shall be true and
correct in all material respects as of the date made and as of the date of the
applicable Closing as though made at that time (except for representations and
warranties that speak as of a specific date) and the Company shall have
performed, satisfied and complied in all material respects with the covenants,
agreements and conditions required by this Agreement to be performed, satisfied
or complied with by the Company at or prior to the date of the applicable
Closing. The Buyer may require a certificate,
18
19
executed by the Chief Executive Officer of the Company, dated as of the date of
such Closing, to the foregoing effect and as to such other matters as may be
reasonably requested by the Buyer.
c. With respect to each Closing called for herein, the Company shall
have issued and have duly executed by the authorized officers of the Company,
and delivered to the Escrow Agent on behalf of the Buyer, the original Preferred
Shares being sold at such Closing.
d. The Common Stock shall be authorized for quotation on the OTC
Bulletin Board Market and trading in the Common Stock on such market shall not
have been suspended by the SEC or other relevant regulatory agency.
e. The Company shall not have received, as of the date of the
applicable Closing, from the National Association of Securities Dealers or any
other relevant regulatory agency, any written or oral communication as to its
actual or potential ineligibility for the Common Stock to continue trading on
the OTC Bulletin Board Market.
f. With respect to each Additional Closing, the conditions for closing
listed in Section 4(1) above shall have been met by the Company, including
without limitation the condition that the Common Stock into which the Series E
Preferred then being sold is convertible, the Warrant Shares receivable upon
exercise of the Warrants then being sold, and the Common Stock representing any
Dividend Shares to be issued in payment of dividends (if any), have all been
registered with the SEC pursuant to the registration statement required under
the Registration Rights Agreement, and such registration statement is still
effective as of the date of such Additional Closing.
g. No statute, rule, regulation, executive order, decree, ruling or
injunction shall have been enacted, entered, promulgated or endorsed by any
court or governmental authority of competent jurisdiction or any self regulatory
organization having authority over the matters contemplated hereby which
restricts or prohibits the consummation of any of the transactions contemplated
herein.
h. The Escrow Agent shall have received on behalf of the Buyer the
opinion of Company counsel, dated as of the date of the First Closing, in the
form attached hereto as Exhibit F.
8. GOVERNING LAW; MISCELLANEOUS.
a. Governing Law. This Agreement shall be governed by and interpreted
in accordance with the laws of the State of Delaware without regard to the
principles of conflict of laws. In the event of any litigation regarding the
interpretation or application of this Agreement, the parties irrevocably consent
to jurisdiction in any of the state or federal courts located in the State of
Delaware and waive their respective rights to object to venue in any such court,
regardless of the convenience or inconvenience thereof to any party. Service of
process in any civil action relating to or arising out of this Agreement
(including also all Exhibits or Addenda hereto) or the transaction(s)
contemplated herein may be accomplished in any manner provided by law. The
19
20
parties hereto agree that a final, non-appealable judgment in any such suit or
proceeding shall be conclusive and may be enforced in other jurisdictions by
suit on such judgment or in any other lawful manner.
b. Counterparts. This Agreement may be executed in two or more
identical counterparts, all of which shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each
party and signature pages from such counterparts have been delivered to the
Escrow Agent on behalf of the other party. In the event any signature page is
delivered by facsimile transmission (which the parties agree is an acceptable
form of delivery), the party using such means of delivery shall cause three (3)
additional originally executed signature pages to be physically delivered to the
Escrow Agent on behalf of the other party within two (2) business days after the
execution and delivery hereof.
c. Headings; Gender, Etc. The headings of this Agreement are for
convenience of reference and shall not form a part of, or affect the
interpretation of this Agreement. As used herein, the masculine shall refer to
the feminine and neuter, the feminine to the masculine and neuter, and the
neuter to the masculine and feminine, as the context may require. As used
herein, unless the context clearly requires otherwise, the words "herein,"
"hereunder" and "hereby," shall refer to this entire Agreement and not only to
the Section or paragraph in which such word appears. If any date specified
herein falls upon a Saturday, Sunday or public or legal holidays, the date shall
be construed to mean the next business day following such Saturday, Sunday or
public or legal holiday. For purposes of this Agreement, a "business day" is any
day other than a Saturday, Sunday or public or legal holiday.
d. Severability. If any provision of this Agreement shall be invalid or
unenforceable in any jurisdiction, such invalidity or unenforceability shall not
affect the validity or enforceability of the remainder of this Agreement in that
jurisdiction or the validity or enforceability of any provision of this
Agreement in any other jurisdiction.
e. Entire Agreement; Amendments. This Agreement and the instruments
referenced herein contain the entire understanding of the parties with respect
to the matters covered herein and therein and, except as specifically set forth
herein or therein, neither the Company nor the Buyer makes any representation,
warranty, covenant or undertaking with respect to such matters. No provision of
this Agreement may be waived or amended other than by an instrument in writing
signed by the party to be charged with enforcement.
f. Notices. Any notices required or permitted to be given under the
terms of this Agreement shall be sent by U. S. Mail or delivered personally or
by courier or via facsimile (if via facsimile, to be followed within three (3)
business days by an original of the notice document via U.S. Mail or courier)
and shall be effective five (5) days after being placed in the mail, if mailed,
certified or registered, return receipt requested, or upon receipt, if delivered
personally or by courier or by facsimile, in each case properly addressed to the
party to receive the same. The addresses for such communications shall be:
20
21
If to the Company: American Biomed, Inc.
10077 Xxxxxx'x Xxxx Xxxx, Xxxxx 000
Xxx Xxxxxxxxx, Xxxxx 00000
Telephone: (000) 000-0000
Facsimile: (000) 000-0000
Attention: Xx. Xxxxxx X. Xxxx, President & CEO
If to the Buyer, at the address on the signature page of this Agreement. Each
party shall provide written notice to the other party of any change in address.
g. Successors and Assigns. This Agreement shall be binding upon and
inure to the benefit of the parties and their respective successors and assigns.
Neither the Company nor the Buyer shall assign this Agreement or any rights or
obligations hereunder without the prior written consent of the other (which
consent shall not be unreasonably withheld), and in any event any assignee of
the Buyer shall be an accredited investor (as defined in Regulation D), in the
written opinion of counsel who is reasonably satisfactory to Seller and in form,
substance and scope reasonably satisfactory to the Seller. Notwithstanding the
foregoing, if applicable, any of the entities constituting the Buyer (if greater
than one (1) entity) may assign its rights hereunder to any of its "affiliates,"
as that term is defined under the 1934 Act, without the consent of the Company;
provided, however, that any such assignment shall not release such assigning
entity from its obligations hereunder unless such obligations are assumed by
such affiliate and the Company has prior to such assignment and assumption
consented in writing to the same; and no such assignment shall be made unless it
is made in accordance with any applicable securities laws of any applicable
jurisdiction. Any request for an assignment made hereunder by the Buyer shall be
accompanied by an opinion by counsel reasonably satisfactory to the Company,
that is in form, substance and scope reasonably satisfactory to the Company,
that such assignment is proper under applicable law.
h. No Third Party Beneficiaries. This Agreement is intended for the
benefit of the parties hereto and their respective permitted successors and
assigns, and is not for the benefit of, nor may any provision hereof be enforced
by, any other person.
i. Survival. Unless this Agreement is terminated under Section 8(1),
the representations and warranties of the Company and the Buyer contained in
Sections 2 and 3 and the agreements and covenants set forth in Sections 4, 5 and
8 shall survive the final Closing of the purchase and sale of Securities
purchased and sold hereby for a period of twelve (12) months after such final
Closing.
j. Publicity. The Company and the Buyer shall have the right to review
before issuance by the other, any press releases or any other public statements
with respect to the transactions contemplated hereby; provided, however, that
the Company shall be entitled, without prior consultation with or approval of
the Buyer, to make any press release or other public disclosure with respect to
such transactions as is required by applicable law and regulations.
21
22
k. Further Assurance. Each party shall do and perform, or cause to be
done and performed, all such further acts and things, and shall execute and
deliver all such other agreements, certificates, instruments and documents, as
the other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.
l. Termination. In the event that the First Closing shall not have
occurred on or before ten (10) business days from the date hereof, this
Agreement shall terminate at the close of business on such date. Neither party
may unilaterally terminate this Agreement after the First Closing for any reason
other than a material breach of this Agreement by the non-terminating party.
Such termination shall not be the sole remedy for a breach of this Agreement by
the non-terminating party, and each party shall retain all of its rights
hereunder at law or in equity. Notwithstanding anything herein to the contrary,
a party whose breach of a covenant or representation and warranty or failure to
satisfy a condition prevented the First Closing or an Additional Closing shall
not be entitled to terminate this Agreement.
m. Remedies. No provision of this Agreement providing for any specific
remedy to a party shall be construed to limit such party to the specific remedy
described, and any other remedy that would otherwise be available to such party
at law or in equity shall be so available. Nothing in this Agreement shall limit
any rights a party may have with any applicable federal or state securities laws
with respect to the transactions contemplated hereby.
IN WITNESS WHEREOF, the Buyer and the Company have caused this
Securities Purchase Agreement to be duly executed as of the date first written
above.
[SIGNATURE PAGE FOLLOWS]
22
23
[SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT DATED
APRIL 29, 1998]
COMPANY:
AMERICAN BIOMED, INC.
By: /s/ XXXXXX X. XXXX
-----------------------------------------
Xx. Xxxxxx X. Xxxx, President and CEO
Attest: /s/ XXXXXX XXXXXXXXXXX
----------------------------
XXXXXX XXXXXXXXXXX Secretary
----------------------------
BUYER:
THE AUGUSTINE FUND, L.P.
By: Augustine Capital Management, Inc.,
its General Partner
By: /s/ XXX XXXXXXXXX
-----------------------------------------
Xx. Xxx Xxxxxxxxx, Vice President
BUYER'S ADDRESS: The Augustine Fund, LP
C/o Augustine Capital Management, Inc.
000 Xxxx Xxxxxxx Xxxx., Xxxxx 0000
Xxxxxxx, Xxxxxxxx 00000
Telecopier Number: 312.427.5396
Attn: Xx. Xxx Xxxxxxxxx
23
24
SECURITIES PURCHASE AGREEMENT
Exhibits
Exhibit A Series D Articles
Exhibit B Series E Articles
Exhibit C Registration Rights Agreement
Exhibit D Escrow Agreement
Exhibit E Warrant to Purchase Common Stock
Exhibit F Opinion of Counsel for American Biomed, Inc.
24
